Prolonged survival with valproic acid use in the EORTC/NCIC temozolomide trial for glioblastoma

M. Weller*, T. Gorlia, J. G. Cairncross, M. J. Van Den Bent, W. Mason, K. Belanger, A. A. Brandes, U. Bogdahn, D. R. Macdonald, P. Forsyth, A. O. Rossetti, D. Lacombe, R. O. Mirimanoff, C. J. Vecht, R. Stupp

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

241 Scopus citations

Fingerprint

Dive into the research topics of 'Prolonged survival with valproic acid use in the EORTC/NCIC temozolomide trial for glioblastoma'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science